Pearls of Bioequivalence Award 2026

Call for Submissions

The EUFEPS/FFQM Pearls of Bioequivalence & Biopharmaceutics Award is aimed at recognizing outstanding research projects in the fields of biopharmaceutics and bioequivalence as well as the development of innovative delivery systems improving the in-vivo performance of their active ingredients and, thereby, extend the existing treatment options.

This award was originally established by the Frankfurt Foundation Quality of Medicines to support the Global Bioequivalence Harmonization Initiative (GBHI). In the future the prize, endowed with 2,000.00 €, will be awarded every second year jointly by the Frankfurt Foundation Quality of Medicines (FFQM) and the European Federation for Pharmaceutical Scientists (EUFEPS).

Pharmaceutical scientists are invited to apply for the award by submitting their own applications. Moreover, it is also possible to nominate research projects from other scientists/groups for this award.

Submission Guidelines:

• Eligibility: Applications must be based on publications in peer reviewed scientific journals or meaningful summaries of research projects related to bioequivalence, biopharmaceutics or the development of innovative drug delivery systems and should not be older than three years at the time of submission.

• Content Requirements: The submissions should demonstrate a significant scientific contribution and show originality and relevance to the field. They should provide insights into methodologies, findings, or applications that contribute in a relevant way to the state of knowledge in bioequivalence and biopharmaceutics.

• Submission Format: All entries must be submitted in a clear and concise format and include the following:
• Title of the publication or project
• Author(s) and their contribution(s) to the project
• Synopsis of the research project or copy of the publication

• Deadline for Submission: November 30, 2025

• Submission Procedure: Applications should be submitted by email to info@frankfurt-foundation.org with the subject line "Pearls of Bioequivalence & Biopharmaceutics Award Submission."

Evaluation Criteria:

Submissions will be evaluated based on the following criteria:

• Scientific novelty and significance
• Clarity and quality of presentation
• Impact on the field of bioequivalence and biopharmaceutics

Award Announcement:

The winner will be announced on the websites of the Frankfurt Foundation Quality of Medicines (https://frankfurt-foundation.org) and EUFEPS (https://eufeps.org). The award will be presented at the EUFEPS Annual Conference 2026 in Naples/Italy (27-29 May 2026).

We look forward to receiving your submission(s) and celebrating the advancements in bioequivalence & biopharmaceutical research.